{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:21:37Z","timestamp":1792686097480,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T00:00:00Z","timestamp":1546819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100011326","name":"London School of Economics and Political Science","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100011326","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s10741-018-9758-0","type":"journal-article","created":{"date-parts":[[2019,1,7]],"date-time":"2019-01-07T00:42:04Z","timestamp":1546821724000},"page":"367-377","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Effect of mineralocorticoid receptor antagonists on cardiac function in patients with heart failure and preserved ejection fraction: a systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1616-6307","authenticated-orcid":false,"given":"Chris J.","family":"Kapelios","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan R.","family":"Murrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7675-7120","authenticated-orcid":false,"given":"Thomas G.","family":"N\u00fchrenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria N.","family":"Montoro Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,7]]},"reference":[{"issue":"8","key":"9758_CR1","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonz\u00e1lez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, Members A\/TF, Reviewers D (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 18(8):891\u2013975","journal-title":"Eur J Heart Fail"},{"issue":"15","key":"9758_CR2","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","volume":"370","author":"B Pitt","year":"2014","unstructured":"Pitt B, Pfeffer MA, Assmann SF, Boineau R, Anand IS, Claggett B, Clausell N, Desai AS, Diaz R, Fleg JL, Gordeev I, Harty B, Heitner JF, Kenwood CT, Lewis EF, O'Meara E, Probstfield JL, Shaburishvili T, Shah SJ, Solomon SD, Sweitzer NK, Yang S, McKinlay SM, Investigators TOPCAT (2014) Spironolactone for heart failure with preserved ejection fraction. N Engl J Med 370(15):1383\u20131392","journal-title":"N Engl J Med"},{"issue":"15","key":"9758_CR3","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1056\/NEJMe1401231","volume":"370","author":"JJ McMurray","year":"2014","unstructured":"McMurray JJ, O'Connor C (2014) Lessons from the TOPCAT trial. N Engl J Med 370(15):1453\u20131454","journal-title":"N Engl J Med"},{"issue":"17","key":"9758_CR4","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1056\/NEJMc1612601","volume":"376","author":"S Denus de","year":"2017","unstructured":"de Denus S, O'Meara E, Desai AS, Claggett B, Lewis EF, Leclair G, Jutras M, Lavoie J, Solomon SD, Pitt B, Pfeffer MA, Rouleau JL (2017) Spironolactone metabolites in TOPCAT - new insights into regional variation. N Engl J Med 376(17):1690\u20131692","journal-title":"N Engl J Med"},{"key":"9758_CR5","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1161\/01.CIR.0000138680.89536.A9","volume":"110","author":"PM Mottram","year":"2004","unstructured":"Mottram PM, Haluska B, Leano R, Cowley D, Stowasser M, Marwick TH (2004) Effect of aldosterone antagonism on myocardial dysfunction in hypertensive patients with diastolic heart failure. Circulation 110:558\u2013565","journal-title":"Circulation"},{"key":"9758_CR6","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1016\/j.jacc.2009.08.021","volume":"54","author":"GJ Mak","year":"2009","unstructured":"Mak GJ, Ledwidge MT, Watson CJ, Phelan DM, Dawkins IR, Murphy NF, Patle AK, Baugh JA, McDonald KM (2009) Natural history of markers of collagen turnover in patients with early diastolic dysfunction and impact of eplerenone. J Am Coll Cardiol 54:1674\u20131682","journal-title":"J Am Coll Cardiol"},{"key":"9758_CR7","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.cardfail.2011.04.007","volume":"17","author":"A Deswal","year":"2011","unstructured":"Deswal A, Richardson P, Bozkurt B, Mann DL (2011) Results of the randomized aldosterone antagonism in heart failure with preserved ejection fraction trial (RAAM-PEF). J Card Fail 17:634\u2013642","journal-title":"J Card Fail"},{"key":"9758_CR8","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1001\/jama.2013.905","volume":"309","author":"F Edelmann","year":"2013","unstructured":"Edelmann F, Wachter R, Schmidt AG, Kraigher-Krainer E, Colantonio C, Kamke W, Duvinage A, Stahrenberg R, Durstewitz K, L\u00f6ffler M, D\u00fcngen HD, Tsch\u00f6pe C, Herrmann-Lingen C, Halle M, Hasenfuss G, Gelbrich G, Pieske B, Aldo DHFI (2013) Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial. JAMA 309:781\u2013791","journal-title":"JAMA"},{"key":"9758_CR9","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.cardfail.2014.05.010","volume":"20","author":"KM Kurrelmeyer","year":"2014","unstructured":"Kurrelmeyer KM, Ashton Y, Xu J, Nagueh SF, Torre-Amione G, Deswal A (2014) Effects of spironolactone treatment in elderly women with heart failure and preserved left ventricular ejection fraction. J Card Fail 20:560\u2013568","journal-title":"J Card Fail"},{"key":"9758_CR10","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","volume":"70","author":"CW Yancy","year":"2017","unstructured":"Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, Drazner MH, Filippatos GS, Fonarow GC, Givertz MM, Hollenberg SM, Lindenfeld J, Masoudi FA, McBride PE, Peterson PN, Stevenson LW, Westlake C (2017) 2017 ACC\/AHA\/HFSA focused update of the 2013 ACCF\/AHA guideline for the management of heart failure. J Am Coll Cardiol 70:776\u2013803. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2017.04.025","journal-title":"J Am Coll Cardiol"},{"key":"9758_CR11","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.jacc.2015.02.018","volume":"65","author":"M-L Cheng","year":"2015","unstructured":"Cheng M-L, Wang C-H, Shiao M-S, Liu MH, Huang YY, Huang CY, Mao CT, Lin JF, Ho HY, Yang NI (2015) Metabolic disturbances identified in plasma are associated with outcomes in patients with heart failure: diagnostic and prognostic value of metabolomics. J Am Coll Cardiol 65:1509\u20131520. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2015.02.018","journal-title":"J Am Coll Cardiol"},{"key":"9758_CR12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12916-014-0261-8","volume":"13","author":"Y Chen","year":"2015","unstructured":"Chen Y, Wang H, Lu Y, Huang X, Liao Y, Bin J (2015) Effects of mineralocorticoid receptor antagonists in patients with preserved ejection fraction: a meta-analysis of randomized clinical trials. BMC Med 13:10","journal-title":"BMC Med"},{"issue":"1","key":"9758_CR13","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1161\/CIRCULATIONAHA.114.013255","volume":"131","author":"MA Pfeffer","year":"2015","unstructured":"Pfeffer MA, Claggett B, Assmann SF, Boineau R, Anand IS, Clausell N, Desai AS, Diaz R, Fleg JL, Gordeev I, Heitner JF, Lewis EF, O'Meara E, Rouleau JL, Probstfield JL, Shaburishvili T, Shah SJ, Solomon SD, Sweitzer NK, McKinlay SM, Pitt B (2015) Regional variation in patients and outcomes in the treatment of preserved cardiac function heart failure with an aldosterone antagonist (TOPCAT) trial. Circulation 131(1):34\u201342","journal-title":"Circulation"},{"issue":"10","key":"9758_CR14","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002137","volume":"4","author":"A Pandey","year":"2015","unstructured":"Pandey A, Garg S, Matulevicius SA, Shah AM, Garg J, Drazner MH, Amin A, Berry JD, Marwick TH, Marso SP, de Lemos JA, Kumbhani DJ (2015) Effect of mineralocorticoid receptor antagonists on cardiac structure and function in patients with diastolic dysfunction and heart failure with preserved ejection fraction: a meta-analysis and systematic review. J Am Heart Assoc 4(10):e002137","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"9758_CR15","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1161\/CIRCHEARTFAILURE.115.002249","volume":"8","author":"AM Shah","year":"2015","unstructured":"Shah AM, Claggett B, Sweitzer NK, Shah SJ, Deswal A, Anand IS, Fleg JL, Pitt B, Pfeffer MA, Solomon SD (2015) Prognostic importance of changes in cardiac structure and function in heart failure with preserved ejection fraction and the impact of spironolactone. Circ Heart Fail 8(6):1052\u20131058","journal-title":"Circ Heart Fail"},{"issue":"17","key":"9758_CR16","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/j.jacc.2016.07.763","volume":"68","author":"W Kosmala","year":"2016","unstructured":"Kosmala W, Rojek A, Przewlocka-Kosmala M, Wright L, Mysiak A, Marwick TH (2016) Effect of aldosterone antagonism on exercise tolerance in heart failure with preserved ejection fraction. J Am Coll Cardiol 68(17):1823\u20131834","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"9758_CR17","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1111\/jgs.14940","volume":"65","author":"B Upadhya","year":"2017","unstructured":"Upadhya B, Hundley WG, Brubaker PH, Morgan TM, Stewart KP, Kitzman DW (2017) Effect of spironolactone on exercise tolerance and arterial function in older adults with heart failure with preserved ejection fraction. J Am Geriatr Soc 65(11):2374\u20132382","journal-title":"J Am Geriatr Soc"},{"key":"9758_CR18","doi-asserted-by":"publisher","unstructured":"Kosmala W, Przewlocka-Kosmala M, Marwick TH (2017) Association of active and passive components of LV diastolic filling with exercise intolerance in heart failure with preserved ejection fraction: mechanistic insights from spironolactone response. JACC Cardiovasc Imaging. \n                    https:\/\/doi.org\/10.1016\/j.jcmg.2017.10.007","DOI":"10.1016\/j.jcmg.2017.10.007"},{"issue":"7","key":"9758_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7):e1000097","journal-title":"PLoS Med"},{"issue":"1","key":"9758_CR20","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s12872-016-0425-x","volume":"16","author":"NM Berbenetz","year":"2016","unstructured":"Berbenetz NM, Mrkobrada M (2016) Mineralocorticoid receptor antagonists for heart failure: systematic review and meta-analysis. BMC Cardiovasc Disord 16(1):246","journal-title":"BMC Cardiovasc Disord"},{"key":"9758_CR21","unstructured":"Higgins J, Green S (2008) Cochrane handbook for systematic reviews of interventions Version 5.0.0 ed: Cochrane Collaboration. Available online at: \n                    https:\/\/training.cochrane.org\n                    \n                  . Accessed 18 Aug 2018"},{"issue":"7650","key":"9758_CR22","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Sch\u00fcnemann HJ, GRADE Working Group (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336(7650):924\u2013926","journal-title":"BMJ"},{"issue":"12","key":"9758_CR23","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/ejhf.813","volume":"19","author":"O Chioncel","year":"2017","unstructured":"Chioncel O, Lainscak M, Seferovic PM, Anker SD, Crespo-Leiro MG, Harjola VP, Parissis J, Laroche C, Piepoli MF, Fonseca C, Mebazaa A, Lund L, Ambrosio GA, Coats AJ, Ferrari R, Ruschitzka F, Maggioni AP, Filippatos G (2017) Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC heart failure long-term registry. Eur J Heart Fail 19(12):1574\u20131585","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"9758_CR24","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1093\/ehjci\/jex005","volume":"18","author":"E Donal","year":"2017","unstructured":"Donal E, Lund LH, Oger E, Bosseau C, Reynaud A, Hage C, Drouet E, Daubert JC, Linde C, Investigators KR, Investigators KR (2017) Importance of combined left atrial size and estimated pulmonary pressure for clinical outcome in patients presenting with heart failure with preserved ejection fraction. Eur Heart J Cardiovasc Imaging 18(6):629\u2013635","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"9","key":"9758_CR25","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1002\/ejhf.1220","volume":"20","author":"JF Nauta","year":"2018","unstructured":"Nauta JF, Hummel YM, van der Meer P, Lam CSP, Voors AA, van Melle JP (2018) Correlation with invasive left ventricular filling pressures and prognostic relevance of the echocardiographic diastolic parameters used in the 2016 ESC heart failure guidelines and in the 2016 ASE\/EACVI recommendations: a systematic review in patients with heart failure with preserved ejection fraction. Eur J Heart Fail 20(9):1303\u20131311","journal-title":"Eur J Heart Fail"},{"key":"9758_CR26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1471-2288-14-135","volume":"14","author":"X Wan","year":"2014","unstructured":"Wan X, Wang W, Liu J, Tong T (2014) Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range. BMC Med Res Methodol 14:135","journal-title":"BMC Med Res Methodol"},{"key":"9758_CR27","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.jacc.2006.08.062","volume":"49","author":"H Persson","year":"2007","unstructured":"Persson H, Lonn E, Edner M, Baruch L, Lang CC, Morton JJ, Ostergren J, RS MK, Investigators of the CHARM Echocardiographic Substudy-CHARMES (2007) Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence: results from the CHARM echocardiographic substudy-CHARMES. J Am Coll Cardiol 49:687\u2013694","journal-title":"J Am Coll Cardiol"},{"key":"9758_CR28","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1161\/CIRCULATIONAHA.110.011031","volume":"124","author":"MR Zile","year":"2011","unstructured":"Zile MR, Gottdiener JS, Hetzel SJ, McMurray JJ, Komajda M, McKelvie R, Baicu CF, Massie BM, Carson PE, Investigators I-PRESERVE (2011) Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction. Circulation 124:2491\u20132501","journal-title":"Circulation"},{"key":"9758_CR29","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.ijcard.2016.07.091","volume":"221","author":"P Banerjee","year":"2016","unstructured":"Banerjee P, Motiwala A, Mustafa HM, Gani MA, Fourali S, Ali D (2016) Does left ventricular diastolic dysfunction progress through stages? Insights from a community heart failure study. Int J Cardiol 221:850\u2013854","journal-title":"Int J Cardiol"},{"issue":"7","key":"9758_CR30","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1002\/ejhf.291","volume":"17","author":"E Donal","year":"2015","unstructured":"Donal E, Lund LH, Oger E, Hage C, Persson H, Reynaud A, Ennezat PV, Bauer F, Drouet E, Linde C, Daubert C, investigators KR (2015) New echocardiographic predictors of clinical outcome in patients presenting with heart failure and a preserved left ventricular ejection fraction: a subanalysis of the Ka (Karolinska) Ren (Rennes) study. Eur J Heart Fail 17(7):680\u2013688","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"9758_CR31","doi-asserted-by":"publisher","first-page":"H1402","DOI":"10.1152\/ajpheart.00696.2015","volume":"310","author":"PG Rodrigues","year":"2016","unstructured":"Rodrigues PG, Leite-Moreira AF, Falc\u00e3o-Pires I (2016) Myocardial reverse remodeling: how far can we rewind? Am J Physiol Heart Circ Physiol 310(11):H1402\u2013H1422","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"11","key":"9758_CR32","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1093\/eurheartj\/ehm091","volume":"28","author":"A Ahmed","year":"2007","unstructured":"Ahmed A, Zannad F, Love TE, Tallaj J, Gheorghiade M, Ekundayo OJ, Pitt B (2007) A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failure. Eur Heart J 28(11):1334\u20131343","journal-title":"Eur Heart J"},{"issue":"4","key":"9758_CR33","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/ehjcvp\/pvv026","volume":"1","author":"ML Krogager","year":"2015","unstructured":"Krogager ML, Eggers-Kaas L, Aasbjerg K, Mortensen RN, K\u00f8ber L, Gislason G, Torp-Pedersen C, S\u00f8gaard P (2015) Short-term mortality risk of serum potassium levels in acute heart failure following myocardial infarction. Eur Heart J Cardiovasc Pharmacother 1(4):245\u2013251","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"12","key":"9758_CR34","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1016\/j.amjcard.2016.08.078","volume":"118","author":"S Hoss","year":"2016","unstructured":"Hoss S, Elizur Y, Luria D, Keren A, Lotan C, Gotsman I (2016) Serum potassium levels and outcome in patients with chronic heart failure. Am J Cardiol 118(12):1868\u20131874","journal-title":"Am J Cardiol"},{"issue":"4","key":"9758_CR35","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s10741-018-9689-9","volume":"23","author":"G Bazoukis","year":"2018","unstructured":"Bazoukis G, Thomopoulos C, Tse G, Tsioufis C (2018) Is there a blood pressure lowering effect of MRAs in heart failure? An overview and meta-analysis. Heart Fail Rev 23(4):547\u2013553","journal-title":"Heart Fail Rev"},{"key":"9758_CR36","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1056\/NEJMoa0801369","volume":"358","author":"NS Beckett","year":"2008","unstructured":"Beckett NS, Peters R, Fletcher AE, Staessen JA, Liu L, Dumitrascu D, Stoyanovsky V, Antikainen RL, Nikitin Y, Anderson C, Belhani A, Forette F, Rajkumar C, Thijs L, Banya W, Bulpitt CJ, HYVET Study Group (2008) Treatment of hypertension in patients 80\u00a0years of age or older. N Engl J Med 358:1887\u20131898","journal-title":"N Engl J Med"},{"key":"9758_CR37","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","volume":"34","author":"G Mancia","year":"2013","unstructured":"Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, B\u00f6hm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F, Redon J, Dominiczak A, Narkiewicz K, Nilsson PM, Burnier M, Viigimaa M, Ambrosioni E, Caufield M, Coca A, Olsen MH, Schmieder RE, Tsioufis C, van de Borne P, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Clement DL, Coca A, Gillebert TC, Tendera M, Rosei EA, Ambrosioni E, Anker SD, Bauersachs J, Hitij JB, Caulfield M, De Buyzere M, De Geest S, Derumeaux GA, Erdine S, Farsang C, Funck-Brentano C, Gerc V, Germano G, Gielen S, Haller H, Hoes AW, Jordan J, Kahan T, Komajda M, Lovic D, Mahrholdt H, Olsen MH, Ostergren J, Parati G, Perk J, Polonia J, Popescu BA, Reiner Z, Ryd\u00e9n L, Sirenko Y, Stanton A, Struijker-Boudier H, Tsioufis C, van de Borne P, Vlachopoulos C, Volpe M, Wood DA (2013) 2013 ESH\/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 34:2159\u20132219","journal-title":"Eur Heart J"},{"key":"9758_CR38","unstructured":"SPIRRIT study. Protocol available online at: \n                    www.clinicaltrials.gov\n                    \n                  . Accessed 22 August 2018"},{"issue":"1\u20132","key":"9758_CR39","first-page":"759","volume":"86","author":"E Chan","year":"2016","unstructured":"Chan E, Giallauria F, Vigorito C, Smart NA (2016) Exercise training in heart failure patients with preserved ejection fraction: a systematic review and meta-analysis. Monaldi Arch Chest Dis 86(1\u20132):759","journal-title":"Monaldi Arch Chest Dis"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-018-9758-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10741-018-9758-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-018-9758-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T19:15:16Z","timestamp":1578338116000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10741-018-9758-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,7]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["9758"],"URL":"https:\/\/doi.org\/10.1007\/s10741-018-9758-0","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,7]]},"assertion":[{"value":"7 January 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}